Evidence map›Paper›PMID 31409922›Full record

Trial reportLeukemia2020

In vivo vaccination effect in multiple myeloma patients treated with the monoclonal antibody isatuximab.

Djordje Atanackovic, Sara Yousef, Christa Shorter, Srinivas K Tantravahi, Mary Steinbach, Fiorella Iglesias, Douglas Sborov, Sabarinath Venniyil Radhakrishnan, Marielle Chiron, Rodney Miles and 3 more

Abstract readClinical TrialLetterMulticenter Study
PubMed Publisher
In one paragraph

Trial report in Leukemia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Djordje AtanackovicMultiple Myeloma Program, Hematology and Hematologic Malignancies, University of Utah/Huntsman Cancer Institute, Salt Lake City, UT, USA. djordje.atanackovic@hci.utah.edu.
Sara YousefMultiple Myeloma Program, Hematology and Hematologic Malignancies, University of Utah/Huntsman Cancer Institute, Salt Lake City, UT, USA.
Christa ShorterMultiple Myeloma Program, Hematology and Hematologic Malignancies, University of Utah/Huntsman Cancer Institute, Salt Lake City, UT, USA.
Srinivas K TantravahiMultiple Myeloma Program, Hematology and Hematologic Malignancies, University of Utah/Huntsman Cancer Institute, Salt Lake City, UT, USA.
Mary SteinbachMultiple Myeloma Program, Hematology and Hematologic Malignancies, University of Utah/Huntsman Cancer Institute, Salt Lake City, UT, USA.
Fiorella IglesiasPediatric Oncology and Hematology, University of Utah, Salt Lake City, UT, USA.
Douglas SborovMultiple Myeloma Program, Hematology and Hematologic Malignancies, University of Utah/Huntsman Cancer Institute, Salt Lake City, UT, USA.
Sabarinath Venniyil RadhakrishnanMultiple Myeloma Program, Hematology and Hematologic Malignancies, University of Utah/Huntsman Cancer Institute, Salt Lake City, UT, USA.
Marielle ChironSanofi, Vitry-sur-Seine, Paris, France.
Rodney MilesDepartment of Pathology, University of Utah, Salt Lake City, UT, USA.
Mohamed SalamaDepartment of Pathology, University of Utah, Salt Lake City, UT, USA.
Nicolaus KrögerDepartment of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Tim LuetkensMultiple Myeloma Program, Hematology and Hematologic Malignancies, University of Utah/Huntsman Cancer Institute, Salt Lake City, UT, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntibodies, NeoplasmAntigens, NeoplasmAntineoplastic Agents, ImmunologicalHumansMembrane ProteinsMultiple MyelomaPilot ProjectsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntibodies, NeoplasmAntigens, NeoplasmAntineoplastic Agents, ImmunologicalCTAG1B protein, humanisatuximabMembrane Proteins

Identifiers

PMID31409922

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.